These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10509326)

  • 1. New approach reduces side effects of high-dose chemotherapy for breast cancer.
    Oncology (Williston Park); 1999 Sep; 13(9):1316. PubMed ID: 10509326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Paclitaxel for treatment of advanced breast cancers].
    Ito Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():259-64. PubMed ID: 11026004
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Docetaxel hydrate for treatment of advanced breast cancers].
    Fujii H
    Nihon Rinsho; 2000 Apr; 58 Suppl():254-8. PubMed ID: 11026003
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
    Altundag O; Altundag K; Gundeslioglu O; Silay YS; Ersoy Y
    Med Hypotheses; 2006; 66(4):857-8. PubMed ID: 16039067
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-intense paclitaxel: deja vu all over again?
    Takimoto CH; Rowinsky EK
    J Clin Oncol; 2003 Aug; 21(15):2810-4. PubMed ID: 12807932
    [No Abstract]   [Full Text] [Related]  

  • 7. [Safety evaluation of paclitaxel injection NK in adjuvant therapy for breast cancer].
    Takahara S; Yamamoto H; Tokushima Y; Shiba E
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1851-6. PubMed ID: 19920387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.
    Lück HJ; Du Bois A; Thomssen C; Lisboa B; Untch M; Köhler G; Hecker D
    Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):34-7. PubMed ID: 9144689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low-dose weekly administration of docetaxel for metastatic breast cancer].
    Kimijima I; Watanabe T; Sagara H; Ohtake T; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):995-9. PubMed ID: 10396330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
    Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
    Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paclitaxel].
    Omuro Y; Sasaki T
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1357-62. PubMed ID: 11681242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxanes in the treatment of breast cancer: a prodigy comes of age.
    Miller KD; Sledge GW
    Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer.
    Tolcher AW
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case successfully treated by desensitization for paclitaxel-associated hypersensitivity reactions].
    Yamatoya Y; Wada Y; Sato S; Morikawa T; Sakata N; Nakata J; Seki K; Wada N; Kamiyama K; Tominaga T
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):271-4. PubMed ID: 17301542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.